Skip to main content
Erschienen in: Pediatric Radiology 12/2014

01.12.2014 | Minisymposium

Scoring of chest CT in children with cystic fibrosis: state of the art

verfasst von: Alistair D. Calder, Andrew Bush, Alan S. Brody, Catherine M. Owens

Erschienen in: Pediatric Radiology | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Chest CT has been proposed as a surrogate outcome measure in the evaluation of cystic fibrosis lung disease. Quantitative evaluation of chest CT findings requires application of a scoring system to derive numerical values. Several scoring systems are in use. These mostly rely on a subjective judgement of the severity and extent of various features of cystic fibrosis lung disease, including bronchiectasis, bronchial wall thickening, mucous plugging and air-trapping. Scores can subsequently be added to produce a total score. The precision or reproducibility of scoring systems has been assessed but with heterogeneous statistical approaches. Total scores appear to have high levels of reproducibility, but this might mask poorer levels of agreement for individual observations and component scores. It can also be questioned whether total scores are biologically meaningful, as compared to assessments of individual features. Various studies suggest that CT scores give an accurate indicator of the severity of disease, and CT scores might be the best predictors of long-term outcome, but data in this area are limited. CT scores are more sensitive than traditional lung-function indices such as FEV; however the lung clearance index, by multiple breath washout, appears to offer comparable sensitivity to CT. It is not clear whether CT scores are adequately responsive to changes in disease severity in the short to medium term; this is a challenge to the use of CT as a surrogate outcome measure for clinical trials of therapies specific to cystic fibrosis. Cystic fibrosis scoring would benefit from greater levels of standardisation in terms of CT techniques, scoring system, training of observers and measures of reproducibility. Automated approaches to quantifying CT parameters might also offer improved precision. The benefits of chest CT must be weighed against the principal drawback of radiation exposure. The case for more widespread use of chest CT would be strengthened if precision of CT scoring were improved.
Literatur
1.
Zurück zum Zitat Bhalla M, Turcios N, Aponte V et al (1991) Cystic fibrosis: Scoring system with thin-section CT. Radiology 179:783–788PubMedCrossRef Bhalla M, Turcios N, Aponte V et al (1991) Cystic fibrosis: Scoring system with thin-section CT. Radiology 179:783–788PubMedCrossRef
2.
Zurück zum Zitat Brody AS, Klein JS, Molina PL et al (2004) High-resolution computed tomography in young patients with cystic fibrosis: Distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 145:32–38PubMedCrossRef Brody AS, Klein JS, Molina PL et al (2004) High-resolution computed tomography in young patients with cystic fibrosis: Distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 145:32–38PubMedCrossRef
3.
Zurück zum Zitat Stick SM, Brennan S, Murray C et al (2009) Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 155:623–628PubMedCrossRef Stick SM, Brennan S, Murray C et al (2009) Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 155:623–628PubMedCrossRef
4.
Zurück zum Zitat Loeve M, van Hal PT, Robinson P et al (2009) The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease. Thorax 64:876–882PubMedCrossRef Loeve M, van Hal PT, Robinson P et al (2009) The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease. Thorax 64:876–882PubMedCrossRef
5.
Zurück zum Zitat Westgard JO, Carey RN, Wold S (1974) Criteria for judging precision and accuracy in method development and evaluation. Clin Chem 20:825–833PubMed Westgard JO, Carey RN, Wold S (1974) Criteria for judging precision and accuracy in method development and evaluation. Clin Chem 20:825–833PubMed
6.
Zurück zum Zitat Ludbrook J (2002) Statistical techniques for comparing measurers and methods of measurement: A critical review. Clin Exp Pharmacol Physiol 29:527–536PubMedCrossRef Ludbrook J (2002) Statistical techniques for comparing measurers and methods of measurement: A critical review. Clin Exp Pharmacol Physiol 29:527–536PubMedCrossRef
7.
Zurück zum Zitat Davis SD, Fordham LA, Brody A et al (2007) Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 175:943–950PubMedCrossRef Davis SD, Fordham LA, Brody A et al (2007) Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 175:943–950PubMedCrossRef
8.
Zurück zum Zitat Owens CM, Aurora P, Stanojevic S et al (2011) London cystic fibrosis collaboration. Lung clearance index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 66:481–488PubMedCrossRef Owens CM, Aurora P, Stanojevic S et al (2011) London cystic fibrosis collaboration. Lung clearance index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 66:481–488PubMedCrossRef
9.
Zurück zum Zitat Nasr SZ, Kuhns LR, Brown RW et al (2001) Use of computerized tomography and chest X-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: A preliminary study. Pediatr Pulmonol 31:377–382PubMedCrossRef Nasr SZ, Kuhns LR, Brown RW et al (2001) Use of computerized tomography and chest X-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: A preliminary study. Pediatr Pulmonol 31:377–382PubMedCrossRef
10.
Zurück zum Zitat Nasr SZ, Gordon D, Sakmar E et al (2006) High resolution computerized tomography of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis patients. Pediatr Pulmonol 41:1129–1137PubMedCrossRef Nasr SZ, Gordon D, Sakmar E et al (2006) High resolution computerized tomography of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis patients. Pediatr Pulmonol 41:1129–1137PubMedCrossRef
11.
Zurück zum Zitat Brody AS, Kosorok MR, Li Z et al (2006) Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 21:14–21PubMedCrossRef Brody AS, Kosorok MR, Li Z et al (2006) Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 21:14–21PubMedCrossRef
12.
Zurück zum Zitat De Jong PA, Ottink MD, Robben SG et al (2004) Pulmonary disease assessment in cystic fibrosis: Comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 231:434–439PubMedCrossRef De Jong PA, Ottink MD, Robben SG et al (2004) Pulmonary disease assessment in cystic fibrosis: Comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 231:434–439PubMedCrossRef
13.
Zurück zum Zitat Loeve M, Krestin GP, Rosenfeld M et al (2012) Chest computed tomography: A validated surrogate endpoint of cystic fibrosis lung disease? Eur Respir J 42:844–857PubMedCrossRef Loeve M, Krestin GP, Rosenfeld M et al (2012) Chest computed tomography: A validated surrogate endpoint of cystic fibrosis lung disease? Eur Respir J 42:844–857PubMedCrossRef
14.
Zurück zum Zitat De Jong PA, Tiddens HA (2007) Cystic fibrosis specific computed tomography scoring. Proc Am Thorac Soc 4:338–342PubMedCrossRef De Jong PA, Tiddens HA (2007) Cystic fibrosis specific computed tomography scoring. Proc Am Thorac Soc 4:338–342PubMedCrossRef
15.
Zurück zum Zitat Brenner H, Kliebsch U (1996) Dependence of weighted kappa coefficients on the number of categories. Epidemiology 7:199–202PubMedCrossRef Brenner H, Kliebsch U (1996) Dependence of weighted kappa coefficients on the number of categories. Epidemiology 7:199–202PubMedCrossRef
16.
Zurück zum Zitat Gwet KL (2012) Handbook of inter-rater reliability, 3rd edn. Advanced Analytics, Gaithersburg Gwet KL (2012) Handbook of inter-rater reliability, 3rd edn. Advanced Analytics, Gaithersburg
17.
Zurück zum Zitat Long FR, Williams RS, Castile R (2004) Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr 144:154–161PubMedCrossRef Long FR, Williams RS, Castile R (2004) Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr 144:154–161PubMedCrossRef
18.
Zurück zum Zitat De Jong PA, Lindblad A, Rubin L et al (2006) Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 61:80–85PubMedCentralPubMedCrossRef De Jong PA, Lindblad A, Rubin L et al (2006) Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 61:80–85PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Tepper LA, Utens E, Caudri (2013) Impact of bronchiectasis and trapped air on quality of life and exacerbations in CF. Eur Respir J 42:371–379PubMedCrossRef Tepper LA, Utens E, Caudri (2013) Impact of bronchiectasis and trapped air on quality of life and exacerbations in CF. Eur Respir J 42:371–379PubMedCrossRef
20.
Zurück zum Zitat Buyse M, Sargent DJ, Grothey A et al (2010) Biomarkers and surrogate end points—the challenge of statistical validation. Nat Rev Clin Oncol 7:309–317PubMedCrossRef Buyse M, Sargent DJ, Grothey A et al (2010) Biomarkers and surrogate end points—the challenge of statistical validation. Nat Rev Clin Oncol 7:309–317PubMedCrossRef
21.
Zurück zum Zitat Gupta K, Gupta J, Singh S (2010) Surrogate endpoints: How reliable are they? J Clin Res Best Pract 8:1–6 Gupta K, Gupta J, Singh S (2010) Surrogate endpoints: How reliable are they? J Clin Res Best Pract 8:1–6
23.
Zurück zum Zitat Ramsey BW (2007) Use of lung imaging studies as outcome measures for development of new therapies in cystic fibrosis. Proc Am Thorac Soc 4:359–563PubMedCentralPubMedCrossRef Ramsey BW (2007) Use of lung imaging studies as outcome measures for development of new therapies in cystic fibrosis. Proc Am Thorac Soc 4:359–563PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat De Jong PA, Nakano Y, Lequin MH et al (2004) Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 23:93–97PubMedCrossRef De Jong PA, Nakano Y, Lequin MH et al (2004) Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 23:93–97PubMedCrossRef
25.
Zurück zum Zitat Demirkazik FB, Ariyürek OM, Ozçelik U et al (2001) High resolution CT in children with cystic fibrosis: Correlation with pulmonary functions and radiographic scores. Eur J Radiol 37:54–59PubMedCrossRef Demirkazik FB, Ariyürek OM, Ozçelik U et al (2001) High resolution CT in children with cystic fibrosis: Correlation with pulmonary functions and radiographic scores. Eur J Radiol 37:54–59PubMedCrossRef
26.
Zurück zum Zitat Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A (2006) Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 63:129–134CrossRef Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A (2006) Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 63:129–134CrossRef
27.
Zurück zum Zitat Ellemunter H, Fuchs SI, Unsinn KM et al (2010) Sensitivity of lung clearance index and chest computed tomography in early CF lung disease. Respir Med 104:1834–1842PubMedCrossRef Ellemunter H, Fuchs SI, Unsinn KM et al (2010) Sensitivity of lung clearance index and chest computed tomography in early CF lung disease. Respir Med 104:1834–1842PubMedCrossRef
28.
Zurück zum Zitat Sanders DB, Li Z, Brody AS, Farrell PM (2011) Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis. Am J Respir Crit Care Med 184:816–821PubMedCentralPubMedCrossRef Sanders DB, Li Z, Brody AS, Farrell PM (2011) Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis. Am J Respir Crit Care Med 184:816–821PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Simanovsky N, Cohen-Cymberknoh M, Shoseyov D et al (2013) Differences in the pattern of structural abnormalities on CT in patients with cystic fibrosis and pancreatic sufficiency or insufficiency. Chest 144:208–241PubMedCrossRef Simanovsky N, Cohen-Cymberknoh M, Shoseyov D et al (2013) Differences in the pattern of structural abnormalities on CT in patients with cystic fibrosis and pancreatic sufficiency or insufficiency. Chest 144:208–241PubMedCrossRef
30.
Zurück zum Zitat Sly PD, Brennan S, Gangell C et al (2009) Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 180:146–152PubMedCrossRef Sly PD, Brennan S, Gangell C et al (2009) Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 180:146–152PubMedCrossRef
31.
Zurück zum Zitat Loeve M, Hop WC, de Bruijne M et al (2012) Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 185:1096–1103PubMedCrossRef Loeve M, Hop WC, de Bruijne M et al (2012) Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 185:1096–1103PubMedCrossRef
32.
Zurück zum Zitat Brody AS, Sucharew H, Campbell JD et al (2005) Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med 172:1128–1132PubMedCrossRef Brody AS, Sucharew H, Campbell JD et al (2005) Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med 172:1128–1132PubMedCrossRef
33.
Zurück zum Zitat Loeve M, Gerbrands K, Hop WC et al (2011) Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis. Chest 140:178–185PubMedCrossRef Loeve M, Gerbrands K, Hop WC et al (2011) Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis. Chest 140:178–185PubMedCrossRef
34.
Zurück zum Zitat Byrnes CA, Vidmar S, Cheney JL et al (2013) Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax 68:643–651PubMedCentralPubMedCrossRef Byrnes CA, Vidmar S, Cheney JL et al (2013) Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax 68:643–651PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat Shah RM, Sexauer W, Ostrum BJ et al (1997) High-resolution CT in the acute exacerbation of cystic fibrosis: Evaluation of acute findings, reversibility of those findings, and clinical correlation. AJR Am J Roentgenol 169:375–380PubMedCrossRef Shah RM, Sexauer W, Ostrum BJ et al (1997) High-resolution CT in the acute exacerbation of cystic fibrosis: Evaluation of acute findings, reversibility of those findings, and clinical correlation. AJR Am J Roentgenol 169:375–380PubMedCrossRef
36.
Zurück zum Zitat Brody AS, Molina PL, Klein JS et al (1999) High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate. Pediatr Radiol 29:731–735PubMedCrossRef Brody AS, Molina PL, Klein JS et al (1999) High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate. Pediatr Radiol 29:731–735PubMedCrossRef
37.
Zurück zum Zitat Horsley AR, Davies JC, Gray RD et al (2013) Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax 638:532–539CrossRef Horsley AR, Davies JC, Gray RD et al (2013) Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax 638:532–539CrossRef
38.
Zurück zum Zitat Moss RB, Rodman D, Spencer LT et al (2004) Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial. Chest 125:509–521PubMedCrossRef Moss RB, Rodman D, Spencer LT et al (2004) Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial. Chest 125:509–521PubMedCrossRef
39.
Zurück zum Zitat Robinson TE, Goris ML, Zhu HJ et al (2005) Dornase Alfa reduces air trapping in children with mild cystic fibrosis lung disease: A quantitative analysis. Chest 128:2327–2335PubMedCrossRef Robinson TE, Goris ML, Zhu HJ et al (2005) Dornase Alfa reduces air trapping in children with mild cystic fibrosis lung disease: A quantitative analysis. Chest 128:2327–2335PubMedCrossRef
40.
Zurück zum Zitat Robinson TE, Leung AN, Northway WH et al (2003) Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease. Am J Respir Crit Care Med 168:588–593PubMedCrossRef Robinson TE, Leung AN, Northway WH et al (2003) Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease. Am J Respir Crit Care Med 168:588–593PubMedCrossRef
41.
Zurück zum Zitat Nasr SZ, Sakmar E, Christodoulou E et al (2010) The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease. Pediatr Pulmonol 45:440–449PubMed Nasr SZ, Sakmar E, Christodoulou E et al (2010) The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease. Pediatr Pulmonol 45:440–449PubMed
42.
Zurück zum Zitat Beydon N, Davis SD, Lombardi E et al (2007) An official American thoracic society/European respiratory society statement: Pulmonary function testing in preschool children. Am J Respir Crit Care Med 175:1304–1345PubMedCrossRef Beydon N, Davis SD, Lombardi E et al (2007) An official American thoracic society/European respiratory society statement: Pulmonary function testing in preschool children. Am J Respir Crit Care Med 175:1304–1345PubMedCrossRef
43.
Zurück zum Zitat Miller MR, Crapo R, Hankinson J et al (2005) General considerations for lung function testing. Eur Respir J 26:153–161PubMedCrossRef Miller MR, Crapo R, Hankinson J et al (2005) General considerations for lung function testing. Eur Respir J 26:153–161PubMedCrossRef
44.
Zurück zum Zitat Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338PubMedCrossRef Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338PubMedCrossRef
45.
Zurück zum Zitat Macintyre N, Crapo RO, Viegi G et al (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26:720–735PubMedCrossRef Macintyre N, Crapo RO, Viegi G et al (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26:720–735PubMedCrossRef
46.
Zurück zum Zitat Wanger J, Clausen JL, Coates A et al (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26:511–522PubMedCrossRef Wanger J, Clausen JL, Coates A et al (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26:511–522PubMedCrossRef
47.
Zurück zum Zitat Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968PubMedCrossRef Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968PubMedCrossRef
48.
Zurück zum Zitat Montaudon M, Berger P, Cangini-Sacher A (2007) Bronchial measurement with three-dimensional quantitative thin-section CT in patients with cystic fibrosis. Radiology 242:573–581PubMedCrossRef Montaudon M, Berger P, Cangini-Sacher A (2007) Bronchial measurement with three-dimensional quantitative thin-section CT in patients with cystic fibrosis. Radiology 242:573–581PubMedCrossRef
49.
Zurück zum Zitat Tanaka N, Matsumoto T, Miura G et al (2003) Air trapping at CT: High prevalence in asymptomatic subjects with normal pulmonary function. Radiology 227:776–785PubMedCrossRef Tanaka N, Matsumoto T, Miura G et al (2003) Air trapping at CT: High prevalence in asymptomatic subjects with normal pulmonary function. Radiology 227:776–785PubMedCrossRef
50.
Zurück zum Zitat Matsuoka S, Uchiyama K, Shima H et al (2003) Bronchoarterial ratio and bronchial wall thickness on high-resolution CT in asymptomatic subjects: correlation with age and smoking. AJR Am J Roentgenol 180:513–518PubMedCrossRef Matsuoka S, Uchiyama K, Shima H et al (2003) Bronchoarterial ratio and bronchial wall thickness on high-resolution CT in asymptomatic subjects: correlation with age and smoking. AJR Am J Roentgenol 180:513–518PubMedCrossRef
51.
Zurück zum Zitat Mott LS, Park J, Gangell CL et al (2013) Distribution of early structural lung age changes due to cystic fibrosis detected with chest computed tomography. J Pediatr 163:243–248PubMedCrossRef Mott LS, Park J, Gangell CL et al (2013) Distribution of early structural lung age changes due to cystic fibrosis detected with chest computed tomography. J Pediatr 163:243–248PubMedCrossRef
52.
Zurück zum Zitat Kapur N, Masel JP, Watson D et al (2011) Bronchoarterial ratio on high-resolution CT scan of the chest in children without pulmonary pathology: Need to redefine bronchial dilatation. Chest 139:1445–1150PubMedCrossRef Kapur N, Masel JP, Watson D et al (2011) Bronchoarterial ratio on high-resolution CT scan of the chest in children without pulmonary pathology: Need to redefine bronchial dilatation. Chest 139:1445–1150PubMedCrossRef
53.
Zurück zum Zitat Hansell DM, Bankier AA, MacMahon H et al (2008) Fleischner society: Glossary of terms for thoracic imaging. Radiology 246:697–722PubMedCrossRef Hansell DM, Bankier AA, MacMahon H et al (2008) Fleischner society: Glossary of terms for thoracic imaging. Radiology 246:697–722PubMedCrossRef
54.
Zurück zum Zitat Mott LS, Park J, Murray CP et al (2012) Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 67:509–516PubMedCrossRef Mott LS, Park J, Murray CP et al (2012) Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 67:509–516PubMedCrossRef
55.
Zurück zum Zitat Robinson TE (2007) Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease. Proc Am Thorac Soc 4:310–315PubMedCrossRef Robinson TE (2007) Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease. Proc Am Thorac Soc 4:310–315PubMedCrossRef
56.
Zurück zum Zitat Mumcuoglu EU, Prescott J, Baker BN et al (2009) Image analysis for cystic fibrosis: Automatic lung airway wall and vessel measurement on CT images. Conf Proc IEEE Eng Med Biol Soc 2009:3545–3548PubMed Mumcuoglu EU, Prescott J, Baker BN et al (2009) Image analysis for cystic fibrosis: Automatic lung airway wall and vessel measurement on CT images. Conf Proc IEEE Eng Med Biol Soc 2009:3545–3548PubMed
57.
Zurück zum Zitat Goris ML, Zhu HJ, Blankenberg F (2003) An automated approach to quantitative air trapping measurements in mild cystic fibrosis. Chest 123:1655–1663PubMedCrossRef Goris ML, Zhu HJ, Blankenberg F (2003) An automated approach to quantitative air trapping measurements in mild cystic fibrosis. Chest 123:1655–1663PubMedCrossRef
58.
Zurück zum Zitat Mott LS, Graniel KG, Park J et al (2013) Assessment of early bronchiectasis in young children with cystic fibrosis is dependent on lung volume. Chest 144:1193–1198PubMedCrossRef Mott LS, Graniel KG, Park J et al (2013) Assessment of early bronchiectasis in young children with cystic fibrosis is dependent on lung volume. Chest 144:1193–1198PubMedCrossRef
59.
Zurück zum Zitat Tiddens HA (2006) Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Paediatr Respir Rev 7:202–208PubMedCrossRef Tiddens HA (2006) Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Paediatr Respir Rev 7:202–208PubMedCrossRef
60.
Zurück zum Zitat O’Connell OJ, McWilliams S, McGarrigle A et al (2012) Radiologic imaging in cystic fibrosis: Cumulative effective dose and changing trends over 2 decades. Chest 141:1575–1583PubMedCrossRef O’Connell OJ, McWilliams S, McGarrigle A et al (2012) Radiologic imaging in cystic fibrosis: Cumulative effective dose and changing trends over 2 decades. Chest 141:1575–1583PubMedCrossRef
Metadaten
Titel
Scoring of chest CT in children with cystic fibrosis: state of the art
verfasst von
Alistair D. Calder
Andrew Bush
Alan S. Brody
Catherine M. Owens
Publikationsdatum
01.12.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 12/2014
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-013-2867-y

Weitere Artikel der Ausgabe 12/2014

Pediatric Radiology 12/2014 Zur Ausgabe

Hermes

Hermes

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.